HCA stock sentiment todayHCA Healthcare, Inc.
Sentiment verdict
Gossip first, financials second — HOT at 88% confidence.
Last updated · cached analysis, refreshes periodically
HCA
HCA Healthcare, Inc.HCA remains the gold standard in healthcare services, leveraging dominant scale and operational efficiency to capture rising patient volumes and surgical shifts.
Pick a name and you can add your own 1-, 3- and 6-month price calls — no account needed. The needle above shows where the crowd sits. Calls lock 48 hours after you make them, so every scorecard stays honest.
You'll show up on boards and The Floor under this name. Add an email later to keep your history.
No account needed. You can add an email later to keep your calls.
Already have an account? Sign in
See exactly how analyst targets, gossip sentiment and momentum are weighted into this 6-month forecast.
Sign in to go Pro →Full model breakdown (analyst / gossip / momentum weights) is a Pro feature. Modelled for HCA. Not financial advice.
Price · last 12 months
Gossip
The narrative centers on HCA's ability to navigate post-pandemic labor inflation better than peers while benefiting from a steady return of high-margin elective procedures and population growth in the Sunbelt.
- ·Recovery in outpatient surgical volumes
- ·Stabilizing nursing labor costs and reduced reliance on contract labor
- ·Strong positioning in high-growth demographic markets (Florida, Texas)
- ·Aggressive share buyback program supporting EPS growth
Financial
HCA demonstrates industry-leading margins (EBITDA margins ~20%) and robust free cash flow. While the debt load is significant, its leverage ratio remains well within management's target of 3.0x-4.0x.
- ·Forward P/E ~17-18x (reasonable vs historical growth)
- ·Consistent ROE exceeding 100% due to aggressive capital structure
- ·Revenue growth sustained by acuity increases and favorable payer mix
Conviction
Whose money is actually in the stock — insider open-market trades and the patience of the institutional holder base.
Mixed conviction — no decisive signal from insiders or the holder base.
- ·No open-market insider trades in the last 120 days.
Pro shows every named insider trade in the window (buyer, title, size, price, and whether it was a pre-scheduled 10b5-1 sale) plus the full holder register split into patient capital and fast money.
Unlock with Pro →Source: SEC EDGAR Form 4 + 13F holder register. Option exercises, grants, gifts and tax withholding are excluded — only open-market purchases and sales count. Not financial advice.
Risks
- ·Potential for Medicaid redeterminations to increase uncompensated care
- ·Sensitivity to government reimbursement rate changes (CMS)
- ·Regulatory scrutiny over market dominance in specific metro areas
Peer temperature
How direct competitors stack up against HCA right now.
- HOTTHCTenet Healthcare
HOTTER — trading at a lower EV/EBITDA multiple while aggressively pivoting to high-margin ambulatory surgery centers (USPI).
See full analysis → - NEUTRALUHSUniversal Health Services
COLDER — faces more volatile earnings due to a higher mix of behavioral health services and acute care labor pressures.
See full analysis → - COLDCHCCommunity Health Systems
COLDER — burdened by a fragile balance sheet and much higher leverage, making it high-risk in a high-rate environment.
See full analysis →
- HCA-1.1%
- THC+1.3%
- UHS-1.2%
- CHC—
Analyst price target
Consensus average of 20 analysts · median 450.00
Source: StockAnalysis.com · updated 2026-09-08
AI-generated analysis for informational purposes only. Not financial advice.